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The immune system is the body’s defense system, it can protect host from 
invading pathogens and clears tumor cells .The vertebrate system is comprised of 
innate immune system and adaptive immune system. As the name suggests, the innate 
immune system is installed along with birth, and is evolutionarily conserved and 
primitive. The innate immune system provides the first line of defense against 
invading pathogens but does not lead to lasting immunity and is not specific for any 
individual pathogen. Adaptive immune system is unique to vertebrates, it is 
established after birth, and does not come into play until there is antigen challenge to 
the organism. T and B cells are important players of acquired immune system, among 
of them, B cells that produce antibodies is the main undertaker of humoral immunity. 
Therefore, B cell developmental processes, molecular mechanisms and effector 
functions become an important research topic in immunology.PHLPP is the pleckstrin 
homology (PH) domain leucine-rich repeat (LRR) protein phosphatase. It can 
promote apoptosis, suppress tumor growth and control circadian rhythms. In addition, 
it can regulate the development and function of Treg cells.We will study the roles of 
PHLPP in B cell development and differentiation. 
In our research, we utilize PHLPP1 germ line knock out mice with B cell 
specific deletion of PHLPP2 (DKO). We found that the GCB percentage of PHLPP 
deletion mice was increased after LCMV infection. In addition, the antibody response 
of PHLPP knockout mice was impaired. We investigate the PHLPP’s functions of 
proliferation and differentiation in vitro,elucidate molecular mechanism of those 
action. We found that the B cell proliferation was caused by enhanced Akt and PKC 
phosphorylation, therefore increased the percentage of GC B cells.In brief, we first 
utilize PHLPP1 and PHLPP2 DKO mice and uncover the function of PHLPP in B cell 
proliferation and differentiation. 
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Fig 1.1 Domain structure of the human PHLPP isozymes 
                (ref?O'Neill.. FEBS J, 2013. 280(2): 572-83) 
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Fig. 1.1.2 Role of PHLPP in cell survival signaling pathways 
                 (ref?O'Neill.. FEBS J, 2013. 280(2): 572-83) 
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